Arrowroot Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
15,195
-163
-1% -$14.5K 0.43% 53
2025
Q4
$1.21M Sell
15,358
-1,846
-11% -$145K 0.44% 50
2025
Q3
$1.38M Buy
17,204
+2,243
+15% +$191K 0.55% 43
2025
Q2
$1.36M Buy
+14,961
New +$1.37M 0.61% 43
2024
Q4
$1.34M Buy
14,731
+91
+0.6% +$8.68K 0.7% 39
2024
Q3
$1.52M Buy
14,640
+48
+0.3% +$4.89K 0.89% 29
2024
Q2
$1.42M Buy
14,592
+31
+0.2% +$2.86K 0.91% 28
2024
Q1
$1.31M Sell
14,561
-795
-5% -$67.4K 0.84% 34
2023
Q4
$1.22M Buy
15,356
+73
+0.5% +$5.49K 0.87% 34
2023
Q3
$1.09M Buy
15,283
+164
+1% +$12.3K 0.86% 36
2023
Q2
$1.16M Buy
15,119
+834
+6% +$64.6K 0.88% 40
2023
Q1
$1.07M Buy
+14,285
New +$1.06M 0.92% 34

Other funds holding CL

Arrowroot Family Office's CL Position: Q1 2026 in Review

Arrowroot Family Office reduced its Colgate-Palmolive (CL) stake by 1.1% in Q1 2026, selling an estimated $14.5K and leaving 15,195 shares worth $1.3M. The position accounts for 0.43% of the portfolio, ranked #53.

Arrowroot Family Office first reported a position in CL in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.52M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Arrowroot Family Office held 15,195 shares of Colgate-Palmolive worth $1.3M as of Q1 2026.
  • Arrowroot Family Office sold 163 Colgate-Palmolive shares in Q1 2026, an estimated $14.5K.
  • Colgate-Palmolive made up 0.43% of Arrowroot Family Office's portfolio in Q1 2026, its #53 holding.
  • Arrowroot Family Office first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 12 quarters since.
  • Arrowroot Family Office's Colgate-Palmolive position peaked at $1.52M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Arrowroot Family Office's 13F filing for Q1 2026, filed 14 May 2026.